Table 2. Clinical data from patients diagnosed with PMAH.
| Patient | Cortisol (µg/dL) | ACTH (pg/mL) | Cortisol post DST (pg/mL) | Cushing/SH |
|---|---|---|---|---|
| 1 | 25.9 | <5 | 32.8 | Cushing |
| 2 | 29.9 | <5 | 25.3 | Cushing |
| 3 | 20.4 | <5 | 8.3 | Cushing |
| 4 | 16.3 | 16.9 | 4.9 | SH |
| 5 | 11.4 | 6.4 | 3.0 | SH |
| 6 | 19.9 | <5 | 27.1 | Cushing |
| 7 | 21.8 | <5 | 18.7 | Cushing |
| 8 | 26.6 | <5 | 1.9 | Cushing |
| 9 | 11.2 | <5 | 7.5 | Cushing |
| 10 | 30.5 | <5 | 27.4 | Cushing |
| 11 | 8.7 | <5 | 6.2 | SH |
| 12 | 25.7 | <5 | 6.4 | Cushing |
| 13 | 27.7 | <5 | 33.2 | Cushing |
| 14 | 10.7 | 3.2 | 2.7 | SH |
| 15 | 13.5 | <2 | 13.9 | SH |
| 16 | 13.5 | <2 | 13.9 | SH |
PMAH: primary macronodular adrenal hyperplasia; DST: dexamethasone suppression test; SH: subclinical hypercortisolism.
Basal cortisol reference value: 3,4-16,8 µg/dL. Cortisol reference value after DST values: < 1,8 µg/dL